​

SIGA Stock (NASDAQ:SIGA)

RevenueOwnershipFinancialsChartTranscripts
SIGA by TradingView

Previous Close

$5.47

52W Range

$4.95 - $9.62

50D Avg

$6.51

200D Avg

$7.15

Market Cap

$376.68M

Avg Vol (3M)

$435.71K

Beta

0.99

Div Yield

$0.60 (11.41%)

SIGA Company Profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

46

IPO Date

Sep 10, 1997

Website

SIGA Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 19
Research and Development$6.53M$5.39M$15.55M
Product Sales and Supportive Services$88.05M$133.33M$11.19M

Fiscal year ends in Dec 25 | Currency in USD

SIGA Financial Summary

Dec 25Dec 24Dec 23
Revenue$94.60M$138.72M$139.92M
Operating Income$23.70M$69.98M$83.62M
Net Income$23.30M$59.21M$68.07M
EBITDA$23.70M$70.52M$84.16M
Basic EPS$0.32$0.83$0.95
Diluted EPS$0.32$0.83$0.95

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q3 25Nov 07, 25 | 4:30 PM
Q2 25Aug 06, 25 | 4:30 PM
Q1 25May 08, 25 | 4:30 PM

Peer Comparison

TickerCompany
SNDLSNDL Inc.
EBSEmergent BioSolutions Inc.
RIGLRigel Pharmaceuticals, Inc.
DRIODarioHealth Corp.
ESPREsperion Therapeutics, Inc.
VTYXVentyx Biosciences, Inc.
AQSTAquestive Therapeutics, Inc.
OLMAOlema Pharmaceuticals, Inc.
CTMXCytomX Therapeutics, Inc.
ORGOOrganogenesis Holdings Inc.